Doban (Dopanum; list a) - antineoplastic. Applied for the treatment of Hodgkin's disease, chronic myeloid leukemia and chronic lymphocytic leukemia. Assign inwards in doses (for adults) 0,008-0.01 g 1 time in 5 days at the control blood count and overall condition of the patient. Absolutely contraindicated in radiation with the number of cells below 3000 1 mm3, chronic myeloid leukemia and acute leukaemia, rapid and acute forms of chlamydia. The form of release: tablets on 0,002 E.
Cm. also Antitumor agents.